Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT

Abattis Bioceuticals Market Cap

Abattis Bioceuticals has a market cap or net worth of $476.00 as of April 25, 2025.

Market Cap
476.00
Enterprise Value
n/a
Revenue
269.58K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00

Market Cap Chart

Since September 19, 2012, Abattis Bioceuticals's market cap has decreased from 1.46M to 476.00, a decrease of -99.97%. That is a compound annual growth rate of -47.12%.

History

DateMarket Cap% Change
Apr 23, 2025476.00-
Dec 30, 2024476.00-
Dec 29, 2023476.00-
Dec 30, 2022476.00-
Dec 31, 2021476.00-99.99%
Dec 31, 20205.95M177.78%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo Inc. 1.63B
Nika Pharmaceuticals 1.02B
Veradigm 746.57M
Glass House Brands 500.84M
Northwest Biotherapeutics 443.51M
Elite Pharmaceuticals 439.57M
CytoDyn 284.32M
BioStem Technologies 245.41M
Market Cap Rankings